4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-052782
CEO and Chairman sold 2,500 shares at an average $50.15 ($125,372)
- CEO and Chairman acquired 2,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ROBINS CHAD M · CEO and Chairman
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-09-29 | Exercise or conversion : show line 1 in the form | +1,900 | $0.33 | $627 | 1,780,080 | D |
| 2020-09-29 | Sale : show line 2 in the form | −1,900 | $50.18 | $95,342 | 1,778,180 | D |
| 2020-10-01 | Exercise or conversion : show line 3 in the form | +600 | $0.33 | $198 | 1,778,780 | D |
| 2020-10-01 | Sale : show line 4 in the form | −600 | $50.05 | $30,030 | 1,778,180 | D |
| Open-market sales · 2,500 sh · avg $50.15 · $125,372 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-09-29 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −1,900 | 192,740 | D |
| 2020-10-01 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −600 | 192,140 | D |
Loading xslF345X03/doc4.xml…